Fantini MC - Search Results

1

TGF-beta as a T cell regulator in colitis and colon cancer.

Becker C, Fantini MC, Neurath MF. Becker C, et al. Among authors: fantini mc. Cytokine Growth Factor Rev. 2006 Feb-Apr;17(1-2):97-106. doi: 10.1016/j.cytogfr.2005.09.004. Epub 2005 Nov 18. Cytokine Growth Factor Rev. 2006. PMID: 16298544 Review.

2

In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy.

Becker C, Fantini MC, Wirtz S, Nikolaev A, Kiesslich R, Lehr HA, Galle PR, Neurath MF. Becker C, et al. Among authors: fantini mc. Gut. 2005 Jul;54(7):950-4. doi: 10.1136/gut.2004.061283. Gut. 2005. PMID: 15951540 Free PMC article.

3

Transforming growth factor beta induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis.

Fantini MC, Becker C, Tubbe I, Nikolaev A, Lehr HA, Galle P, Neurath MF. Fantini MC, et al. Gut. 2006 May;55(5):671-80. doi: 10.1136/gut.2005.072801. Epub 2005 Sep 14. Gut. 2006. PMID: 16162681 Free PMC article.

4

Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7.

Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF. Fantini MC, et al. J Immunol. 2004 May 1;172(9):5149-53. doi: 10.4049/jimmunol.172.9.5149. J Immunol. 2004. PMID: 15100250

5

TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

Becker C, Fantini MC, Schramm C, Lehr HA, Wirtz S, Nikolaev A, Burg J, Strand S, Kiesslich R, Huber S, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Galle PR, Blessing M, Rose-John S, Neurath MF. Becker C, et al. Among authors: fantini mc. Immunity. 2004 Oct;21(4):491-501. doi: 10.1016/j.immuni.2004.07.020. Immunity. 2004. PMID: 15485627 Free article.

6

Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis.

Becker C, Dornhoff H, Neufert C, Fantini MC, Wirtz S, Huebner S, Nikolaev A, Lehr HA, Murphy AJ, Valenzuela DM, Yancopoulos GD, Galle PR, Karow M, Neurath MF. Becker C, et al. Among authors: fantini mc. J Immunol. 2006 Sep 1;177(5):2760-4. doi: 10.4049/jimmunol.177.5.2760. J Immunol. 2006. PMID: 16920909

7

Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells.

Dominitzki S, Fantini MC, Neufert C, Nikolaev A, Galle PR, Scheller J, Monteleone G, Rose-John S, Neurath MF, Becker C. Dominitzki S, et al. Among authors: fantini mc. J Immunol. 2007 Aug 15;179(4):2041-5. doi: 10.4049/jimmunol.179.4.2041. J Immunol. 2007. PMID: 17675459

8

IL-6 signaling promotes tumor growth in colorectal cancer.

Becker C, Fantini MC, Wirtz S, Nikolaev A, Lehr HA, Galle PR, Rose-John S, Neurath MF. Becker C, et al. Among authors: fantini mc. Cell Cycle. 2005 Feb;4(2):217-20. Epub 2005 Feb 3. Cell Cycle. 2005. PMID: 15655344

9

High resolution colonoscopy in live mice.

Becker C, Fantini MC, Neurath MF. Becker C, et al. Among authors: fantini mc. Nat Protoc. 2006;1(6):2900-4. doi: 10.1038/nprot.2006.446. Nat Protoc. 2006. PMID: 17406549

10

EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation.

Wirtz S, Becker C, Fantini MC, Nieuwenhuis EE, Tubbe I, Galle PR, Schild HJ, Birkenbach M, Blumberg RS, Neurath MF. Wirtz S, et al. Among authors: fantini mc. J Immunol. 2005 Mar 1;174(5):2814-24. doi: 10.4049/jimmunol.174.5.2814. J Immunol. 2005. PMID: 15728491

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters